CCNE

CNB Financial Corporation
$30.65
-0.16 (-0.52%)
Mkt Cap 908.13M
Volume 79,820
52W Range 21.19-31.8
Sector Financial Services
Beta 0.65
EPS (TTM) 2.83
P/E Ratio 10.83
Revenue (TTM) 435.94M
Rev Growth (5Y) +16.1%
EPS Growth (5Y) +5.0%
AlphaVal · Fair Value
$39.72
Fair Value · Moderate
22.8% below fair value
AlphaQuality · Grade
C
Banks, Insurers & Asset Managers
54.2 / 100 composite

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 404.86M 360.01M 322.01M 243.70M 209.20M 192.09M 178.81M 149.76M 127.66M 110.12M 101.98M 101.20M
Net Income 66.13M 54.58M 58.02M 63.19M 57.71M 32.74M 40.08M 33.72M 23.86M 20.54M 22.20M 23.07M
EPS 2.51 2.40 2.56 3.26 3.16 1.97 2.63 2.22 1.57 1.42 1.54 1.60
Free Cash Flow 58.65M 55.23M 36.05M 51.76M 52.44M 23.11M 42.86M 41.79M 25.55M 16.64M N/A N/A
FCF / Share 2.38 2.65 1.73 2.46 3.12 1.37 2.83 2.75 1.69 1.16 N/A N/A
Operating CF 64.98M 71.51M 47.02M 64.05M 58.92M 28.76M 51.91M 44.85M 30.76M 26.76M N/A N/A
Total Assets 8.40B 6.19B 5.75B 5.48B 5.33B 4.73B 3.76B 3.22B 2.77B 2.57B N/A N/A
Total Debt 313.24M 145.50M 142.54M 403.10M 125.44M 90.07M 317.89M 315.74M 327.98M 307.62M N/A N/A
Cash & Equiv 527.90M 443.04M 221.87M 106.28M 732.20M 532.69M 192.97M 45.56M 35.34M 29.18M N/A N/A
Book Value 872.13M 610.70M 571.25M 530.76M 442.85M 416.14M 304.97M 262.83M 243.91M 211.78M N/A N/A
Return on Equity 0.08 0.09 0.10 0.12 0.13 0.08 0.13 0.13 0.10 0.10 N/A N/A
CCNE News
Why CNB Financial (CCNE) is a Top Dividend Stock for Your Portfolio
May 22, 2026 08:46 AM · zacks.com
CNB (CCNE) Upgraded to Buy: What Does It Mean for the Stock?
May 18, 2026 09:01 AM · zacks.com
CNB Financial Corporation Announces Quarterly Dividend For Common Stock
May 12, 2026 12:05 PM · globenewswire.com
CNB Financial (CCNE) is a Top Dividend Stock Right Now: Should You Buy?
May 06, 2026 08:46 AM · zacks.com
Is the Options Market Predicting a Spike in CNB Financial Stock?
May 05, 2026 11:40 AM · zacks.com
CNB Financial (CCNE) Could Be a Great Choice
Apr 20, 2026 08:46 AM · zacks.com
Monte Rosa Therapeutics Presents Preclinical Data at American Association for Cancer Research (AACR) Annual Meeting 2026 on the Potential of its Cyclin E1 (CCNE1)-directed Molecular Glue Degrader to Treat CCNE1-amplified Solid Tumors
Apr 20, 2026 03:00 AM · globenewswire.com
Reviewing CNB Financial (NASDAQ:CCNE) & Patriot National Bancorp (NASDAQ:PNBK)
Apr 16, 2026 09:28 PM · defenseworld.net
CNB Financial Corporation Announces Quarterly Dividend for Series A Preferred Stock and Related Depositary Shares Distribution
Apr 14, 2026 12:05 PM · globenewswire.com
Are You Looking for a High-Growth Dividend Stock?
Apr 03, 2026 08:45 AM · zacks.com